Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romosozumab in Fresh Unilateral Hip Fracture
NCT01081678Phase 2Completed
- Sponsor
- Amgen
- Start
- Jun 2010
- Primary completion
- Jun 2012
- Modality
- Monoclonal Antibodies
- Countries
- 24
01
Overview
A Phase 2 trial of romosozumab in hip fracture, sponsored by Amgen. Started Jun 2010; status: completed.
02
Drugs
romosozumab
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT01081678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01081678.